Clinical Trials Logo

Exercise-induced Bronchospasm clinical trials

View clinical trials related to Exercise-induced Bronchospasm.

Filter by:

NCT ID: NCT00662779 Withdrawn - Clinical trials for Exercise-induced Bronchospasm

Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)

EIB
Start date: April 2008
Phase: Phase 3
Study type: Interventional

It is our primary hypothesis that pretreatment with arformoterol will provide superior protection against EIB in children with mild-moderate asthma compared to placebo added to the current asthma regimen. Our secondary hypothesis is that nebulized arformoterol has comparable protection against EIB compared to inhaled formoterol by dry powder inhaler.

NCT ID: NCT00375232 Withdrawn - Clinical trials for Exercise-Induced Bronchospasm

Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes

Start date: October 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if treatment of exercise-induced Bronchospasm with montelukast will help college athletes train more effectively and thus become more competitive in a non ergogenic manner.

NCT ID: NCT00273689 Completed - Clinical trials for Exercise Induced Bronchospasm

Exercise Induced Bronchospasm in Children

Start date: December 2005
Phase: Phase 4
Study type: Interventional

The purpose of the study is to test how well 2 different medications stop asthma symptoms caused by exercising. The two medications that will be tested are "pretreatment with albuterol" and montelukast (Singulair®). Although both medications are used for treating asthma, we don't know which medicine is better at stopping asthma symptoms caused by exercising.

NCT ID: NCT00268723 Completed - Clinical trials for Exercise-induced Bronchospasm

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

Start date: December 2005
Phase: Phase 3
Study type: Interventional

To determine if administration of levalbuterol tartrate HFA MDI in subjects with EIB will be effective in the prevention of EIB and be safe and well-tolerated.

NCT ID: NCT00085774 Completed - Clinical trials for Exercise-induced Bronchospasm

Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma

Start date: June 30, 2004
Phase: Phase 3
Study type: Interventional

This study was designed to examine the effectiveness of two bronchodilator inhalers in patients who have exercise-induced asthma.